A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?

From BugSigDB
Reviewed Marked as Reviewed by Fatima on 2022/05/17
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Forbes JD, Chen CY, Knox NC, Marrie RA, El-Gabalawy H, de Kievit T, Alfa M, Bernstein CN, Van Domselaar G
Journal
Microbiome
Year
2018
Keywords:
16S rRNA gene amplicon sequencing, Bacteria, Gut microbiota, Immune-mediated inflammatory disease, Inflammatory bowel disease, Machine learning classifiers, Multiple sclerosis, Rheumatoid arthritis, Taxonomic biomarkers
BACKGROUND: Immune-mediated inflammatory disease (IMID) represents a substantial health concern. It is widely recognized that IMID patients are at a higher risk for developing secondary inflammation-related conditions. While an ambiguous etiology is common to all IMIDs, in recent years, considerable knowledge has emerged regarding the plausible role of the gut microbiome in IMIDs. This study used 16S rRNA gene amplicon sequencing to compare the gut microbiota of patients with Crohn's disease (CD; N = 20), ulcerative colitis (UC; N = 19), multiple sclerosis (MS; N = 19), and rheumatoid arthritis (RA; N = 21) versus healthy controls (HC; N = 23). Biological replicates were collected from participants within a 2-month interval. This study aimed to identify common (or unique) taxonomic biomarkers of IMIDs using both differential abundance testing and a machine learning approach. RESULTS: Significant microbial community differences between cohorts were observed (pseudo F = 4.56; p = 0.01). Richness and diversity were significantly different between cohorts (pFDR < 0.001) and were lowest in CD while highest in HC. Abundances of Actinomyces, Eggerthella, Clostridium III, Faecalicoccus, and Streptococcus (pFDR < 0.001) were significantly higher in all disease cohorts relative to HC, whereas significantly lower abundances were observed for Gemmiger, Lachnospira, and Sporobacter (pFDR < 0.001). Several taxa were found to be differentially abundant in IMIDs versus HC including significantly higher abundances of Intestinibacter in CD, Bifidobacterium in UC, and unclassified Erysipelotrichaceae in MS and significantly lower abundances of Coprococcus in CD, Dialister in MS, and Roseburia in RA. A machine learning approach to classify disease versus HC was highest for CD (AUC = 0.93 and AUC = 0.95 for OTU and genus features, respectively) followed by MS, RA, and UC. Gemmiger and Faecalicoccus were identified as important features for classification of subjects to CD and HC. In general, features identified by differential abundance testing were consistent with machine learning feature importance. CONCLUSIONS: This study identified several gut microbial taxa with differential abundance patterns common to IMIDs. We also found differentially abundant taxa between IMIDs. These taxa may serve as biomarkers for the detection and diagnosis of IMIDs and suggest there may be a common component to IMID etiology.

Experiment 1


Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): WikiWorks, ChiomaBlessing

Subjects

Location of subjects
Canada
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Crohn's disease Colitis, Granulomatous,CROHN DIS,Crohn Disease,Crohn disease,Crohn's associated gastritis,Crohn's disease,Crohn's disease of colon,Crohn's disease of large bowel,CROHNS DIS,Crohns Disease,Enteritis, Granulomatous,Enteritis, Regional,Gastritis Associated with Crohn Disease,Gastritis Associated with Crohn's Disease,granulomatous colitis,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,pediatric Crohn's disease,regional enteritis,crohn disease,crohn's disease
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
crohn's disease
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
patients with immune-mediated inflammatory disease (IMID)
Group 0 sample size Number of subjects in the control (unexposed) group
23
Group 1 sample size Number of subjects in the case (exposed) group
20
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
8 weeks

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Kruskall-Wallis
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
decreased

Signature 1

Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: Fatima Zohra

Revision editor(s): WikiWorks, Fatima, Merit, ChiomaBlessing

Source: Table 2

Description: Abundant taxa in Crohn's disease patients microbiota relative to healthy controls (HC)

Abundance in Group 1: increased abundance in crohn's disease

NCBI Quality ControlLinks
Actinomyces
Bacillota
Blautia
Carnobacteriaceae
Eggerthella
Faecalicoccus
Gemella
Intestinibacter
Rothia
Streptococcaceae
Streptococcus
unclassified Lachnospiraceae

Revision editor(s): WikiWorks, Fatima, Merit, ChiomaBlessing

Signature 2

Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: Fatima Zohra

Revision editor(s): Fatima, WikiWorks, ChiomaBlessing

Source: Table 2

Description: Abundant taxa in Crohn's disease patients microbiota relative to healthy controls (HC)

Abundance in Group 1: decreased abundance in crohn's disease

NCBI Quality ControlLinks
Asaccharobacter
Clostridia
Clostridium
Coprococcus
Coriobacteriaceae
Faecalibacterium
Fusicatenibacter
Gemmiger
Lachnospira
Lachnospiraceae
Mogibacterium
Oscillibacter
Romboutsia
Ruminococcus
Sporobacter
Subdoligranulum
Turicibacter
unclassified Oscillospiraceae

Revision editor(s): Fatima, WikiWorks, ChiomaBlessing

Experiment 2


Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Ulcerative colitis colitis ulcerative,Colitis, Ulcerative,Left-sided ulcerative (chronic) colitis,Left-sided ulcerative colitis,left-sided ulcerative colitis,Other ulcerative colitis,Other ulcerative colitis (disorder),UC - ulcerative colitis,ulcerative colitis,ulcerative colitis (disease),ulcerative colitis (disorder),Ulcerative colitis, unspecified,ULCERATVE COLITIS UNSPCF,Ulcerative colitis
Group 1 name Corresponds to the case (exposed) group for case-control studies
ulcerative colitis
Group 1 sample size Number of subjects in the case (exposed) group
19

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
decreased

Signature 1

Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: Fatima Zohra

Revision editor(s): WikiWorks, Fatima, Merit, ChiomaBlessing

Source: Table 2

Description: Abundant taxa in Ulcerative colitis patients microbiota relative to healthy controls (HC)

Abundance in Group 1: increased abundance in ulcerative colitis

NCBI Quality ControlLinks
Actinomyces
Anaerofustis
Bifidobacterium
Eggerthella
Faecalicoccus
Gemella
Streptococcaceae
Streptococcus
unclassified Lachnospiraceae

Revision editor(s): WikiWorks, Fatima, Merit, ChiomaBlessing

Signature 2

Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: Fatima Zohra

Revision editor(s): WikiWorks, ChiomaBlessing

Source: Table 2

Description: Abundant taxa in Ulcerative colitis patients microbiota relative to healthy controls (HC)

Abundance in Group 1: decreased abundance in ulcerative colitis

NCBI Quality ControlLinks
Gemmiger
Gordonibacter
Lachnospira
Mogibacterium
Ruminococcus
Sporobacter

Revision editor(s): WikiWorks, ChiomaBlessing

Experiment 3


Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Multiple sclerosis Disseminated Sclerosis,generalized multiple sclerosis,insular sclerosis,MS,MS (Multiple Sclerosis),multiple sclerosis,MULTIPLE SCLEROSIS ACUTE FULMINATING,Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Sclerosis, Multiple,Multiple sclerosis
Group 1 name Corresponds to the case (exposed) group for case-control studies
multiple sceloris

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
decreased

Signature 1

Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: Fatima Zohra

Revision editor(s): WikiWorks, Merit, ChiomaBlessing

Source: Table 2

Description: Abundant taxa in Multiple sclerosis patients microbiota relative to healthy controls (HC)

Abundance in Group 1: increased abundance in multiple sceloris

NCBI Quality ControlLinks
Actinomyces
Anaerofustis
Clostridia
Clostridiaceae
Clostridium
Eggerthella
Faecalicoccus
Streptococcus
Turicibacter

Revision editor(s): WikiWorks, Merit, ChiomaBlessing

Signature 2

Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: Fatima Zohra

Revision editor(s): WikiWorks, ChiomaBlessing

Source: Table 2

Description: Abundant taxa in Multiple sclerosis patients microbiota relative to healthy controls (HC)

Abundance in Group 1: decreased abundance in multiple sceloris

NCBI Quality ControlLinks
Butyricicoccus
Dialister
Faecalibacterium
Fusicatenibacter
Gemmiger
Lachnospira
Sporobacterium
Subdoligranulum

Revision editor(s): WikiWorks, ChiomaBlessing

Experiment 4


Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Rheumatoid arthritis Arthritis or polyarthritis, rheumatic,arthritis or polyarthritis, rheumatic,Arthritis, Rheumatoid,arthritis, rheumatoid,atrophic Arthritis,atrophic arthritis,autoimmune arthritis,Chronic rheumatic arthritis,Proliferative arthritis,RA,RA - Rheumatoid arthritis,RhA - Rheumatoid arthritis,Rheumatic gout,rheumatoid arthritis,Rheumatoid arthritis (disorder),Rheumatoid arthritis NOS,Rheumatoid arthritis NOS (disorder),rheumatoid arthritis, susceptibility to,Rheumatoid disease,Rheumatoid arthritis
Group 1 name Corresponds to the case (exposed) group for case-control studies
arthiritis
Group 1 sample size Number of subjects in the case (exposed) group
21

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
decreased

Signature 1

Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: Fatima Zohra

Revision editor(s): WikiWorks, Fatima, Merit, ChiomaBlessing

Source: Table 2

Description: Abundant taxa in Rheumatoid arthritis patients microbiota relative to healthy controls (HC)

Abundance in Group 1: increased abundance in arthiritis

NCBI Quality ControlLinks
Actinomyces
Bacillota
Eggerthella
Faecalicoccus
Gemella
Rothia
Streptococcaceae
Streptococcus
unclassified Lachnospiraceae

Revision editor(s): WikiWorks, Fatima, Merit, ChiomaBlessing

Signature 2

Reviewed Marked as Reviewed by Fatima on 2022/05/17

Curated date: 2021/01/10

Curator: Fatima Zohra

Revision editor(s): WikiWorks, ChiomaBlessing

Source: Table 2

Description: Abundant taxa in Rheumatoid arthritis patients microbiota relative to healthy controls (HC)

Abundance in Group 1: decreased abundance in arthiritis

NCBI Quality ControlLinks
Anaerofustis
Butyricicoccus
Clostridium
Faecalibacterium
Fusicatenibacter
Gemmiger
Lachnospira
Romboutsia
Roseburia
Sporobacter
Subdoligranulum

Revision editor(s): WikiWorks, ChiomaBlessing